Gilead Sciences, Inc. (TSX:GILD)
28.97
-0.15 (-0.52%)
Oct 6, 2026, 3:42 PM EST
Gilead Sciences Employees
Gilead Sciences had 17,000 employees as of December 31, 2025. The number of employees decreased by 600 or -3.41% compared to the previous year.
Employees
17,000
Change (1Y)
-600
Growth (1Y)
-3.41%
Revenue / Employee
2.54M CAD
Profits / Employee
-270.65K CAD
Market Cap
254.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17,000 | -600 | -3.41% |
| Dec 31, 2024 | 17,600 | -400 | -2.22% |
| Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
| Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
| Dec 31, 2021 | 14,400 | 800 | 5.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Gilead Sciences News
- 16 hours ago - Cognizant announces five-year extension of its work with Gilead Sciences - TheFly
- 1 day ago - Nurix Therapeutics announces second research term extension with Gilead - TheFly
- 5 days ago - More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barrons
- 6 days ago - Gilead put volume heavy and directionally bearish - TheFly
- 11 days ago - Genetic discovery yields clues toward reversal of Alzheimer's brain damage - Reuters
- 11 days ago - NTHM's Index Rebalance Puts Thematic Rotation to Work - ETF Trends
- 19 days ago - Latin America's PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF - Business Wire
- 20 days ago - Gilead announces expanded scope of licensing agreements for lenacapavir - TheFly